Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
Articles by Bina Gidwani
Total Records ( 3 ) for Bina Gidwani
  Mukesh K. Singh , Bina Gidwani , Anshita Gupta , Hemant Dhongade , Chanchal Deep Kaur , Pranita P. Kashyap and D.K. Tripathi
  In the genus Orthosiphon (Lamiaceae), Orthosiphon aristatus, Orthosiphon pallidus, Orthosiphon thymiflorus, Orthosiphon stamineus are widely used in traditional medicine to prevent different diseases such as diabetes, kidney stone, edema, rheumatism, hepatitis, hypertensive and jaundice. A different variety of phytoconstituents has been isolated from the Orthosiphon species which include monoterpenes, diterpenes, triterpenes, saponins, organic acid and flavonoids compound. Antidiabetic, anti-inflammatory, antioxidant, hepatoprotective, analgesic and nephroprotective activities have been reported in the plant extract and phytoconstituents. Hence, the purpose of this review is to provide a comprehensive report about the Orthosiphon genus based on its toxicity in order to identify its therapeutic potential and future prospects for betterment of research.
  Tarun Kumar , Anshita Gupta , Bina Gidwani and Chanchal Deep Kaur
  Euphorbia tithymaloidus is a shrub having a range of activities like anti-inflammatory, antioxidant, anti-malarial, anti-tuberculosis, antifungal, antibacterial, antidaibetic and wound healing etc., but the anthelminthic activity of this plant is still under consideration. In this study carried out the phytochemical and anthelminthic activity of Euphorbia tithymaloidus in order to estimate its potential in treating the intestinal worms. The in vitro anthelmintic activity was performed on ethanolic leaf extract using adult earthworms (Pheretima posthuma). The standard drug used was albendazole in the concentration of 15-60 mg mL–1 to note the paralysis time and death time. The result of the study showed that the ethanolic leaf extract shows the presence of certain phytoconstituents like flavonoids, carbohydrates, steroids and alkaloids. The reaction time was noted as paralysis time and death time for all the concentrations and compared with standard albendazole. The extract exhibited remarkable activity at a concentration of 45 mg mL–1 as compared to standard drug albendazole within a shorter time span of less than 10 min.
  Amber Vyas , Sourav Kisore Das , Deependra Singh , Avinesh Sonker , Bina Gidwani , Vishal Jain and Manju Singh
  Very few drug delivery systems are potent enough to fight against cancer yet gentle enough on the body. The Nanoparticles have been successfully utilized to create a new drug delivery system for treatment of cancer. Study and application of nanoparticles is advancing rapidly within the pharmaceutical field. These nano-sized materials, e.g., “nanoparticles”, take on novel properties and functions that differ markedly from that delivery system presently available in market. The nano-size and surface improved solubility and multi-functionality of nanoparticles. This improves the quality and the biomedical applications of the nanoparticles. The skin provides a physical barrier to the harmful effects of the external environment in the body. The skin cancer appears in the upper layer of the skin. In recent years there has been an exciting increase in the prevalence of skin cancer worldwide. Non-melanoma skin cancer is the most common diagnosed cancer in the UK accounting for a quarter of all new cancer cases. It is a slow growing form of cancer and can be present many years before detection. Several obstacles frequently still encountered with the skin cancer. In general, the best way to eliminate a problem is to eliminate the cause. This article has reviewed nanoparticulate delivery system with a view as to its impact on skin cancer.
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility